Silver Spur Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 4

Silver Spur Therapeutics General Information

Description

Developer of nanotherapeutics designed to improve drug and gene delivery for kidney and cardiovascular diseases. The company offers a peptide amphiphile micelle delivery platform, targeted gene therapies, and small-molecule drug carriers, enabling clinicians to deliver therapeutic agents directly to specific tissues while reducing systemic toxicity and off-target effects.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 955 Deep Valley Drive
  • Unit 4142, Palos Verdes Peninsula
  • Los Angeles, CA 90274
  • United States
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Biotechnology
Corporate Office
  • 955 Deep Valley Drive
  • Unit 4142, Palos Verdes Peninsula
  • Los Angeles, CA 90274
  • United States

Silver Spur Therapeutics Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Silver Spur Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 01-Jul-2026 Completed Startup
3. Accelerator/Incubator 17-Jun-2025 Completed Startup
2. Accelerator/Incubator 01-Jan-2024 Completed Startup
1. University Spin-Out 06-Jun-2023 Completed Startup
To view Silver Spur Therapeutics’s complete valuation and funding history, request access »

Silver Spur Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Silver Spur Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
StoryHouse Ventures Venture Capital Minority
Techstars Accelerator/Incubator Minority
National Institutes of Health Government
University of Southern California University
To view Silver Spur Therapeutics’s complete investors history, request access »

Silver Spur Therapeutics FAQs

  • When was Silver Spur Therapeutics founded?

    Silver Spur Therapeutics was founded in 2023.

  • Where is Silver Spur Therapeutics headquartered?

    Silver Spur Therapeutics is headquartered in Los Angeles, CA.

  • What is the size of Silver Spur Therapeutics?

    Silver Spur Therapeutics has 3 total employees.

  • What industry is Silver Spur Therapeutics in?

    Silver Spur Therapeutics’s primary industry is Drug Delivery.

  • Is Silver Spur Therapeutics a private or public company?

    Silver Spur Therapeutics is a Private company.

  • What is Silver Spur Therapeutics’s current revenue?

    The current revenue for Silver Spur Therapeutics is .

  • How much funding has Silver Spur Therapeutics raised over time?

    Silver Spur Therapeutics has raised $220K.

  • Who are Silver Spur Therapeutics’s investors?

    StoryHouse Ventures, Techstars, National Institutes of Health, and University of Southern California have invested in Silver Spur Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process